Lyell Immunopharma, Inc. Stock Forecast
Red day on Friday for Lyell Immunopharma, Inc.
(Updated on Apr 26, 2024)
The Lyell Immunopharma, Inc. stock price fell by -1.36% on the last day (Friday, 26th Apr 2024) from $2.20 to $2.17. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 4.74% from a day low at $2.11 to a day high of $2.21. The price has fallen in 7 of the last 10 days and is down by -27.91% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -157 thousand shares and in total, 343 thousand shares were bought and sold for approximately $744.59 thousand.
The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.05 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 13.23% during the next 3 months and, with a 90% probability hold a price between $2.32 and $3.75 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
LYEL Signals & Forecast
There are few to no technical positive signals at the moment. The Lyell Immunopharma, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $2.30 and $2.24. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, March 01, 2024, and so far it has fallen -29.32%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Support, Risk & Stop-loss for Lyell Immunopharma, Inc. stock
On the downside, the stock finds support just below today's level from accumulated volume at $2.04 and $1.99. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Lyell Immunopharma, Inc. finds support just below today's level at $2.04. If this is broken, then the next support from accumulated volume will be at $1.99 and $1.92.
This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.100 between high and low, or 4.74%. For the last week the stock has had daily average volatility of 9.83%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (LYEL) For The Upcoming Trading Day Of Monday 29th
For the upcoming trading day on Monday, 29th we expect Lyell Immunopharma, Inc. to open at $2.16, and during the day (based on 14 day Average True Range), to move between $1.94 and $2.40, which gives a possible trading interval of +/-$0.226 (+/-10.40%) up or down from last closing price. If Lyell Immunopharma, Inc. takes out the full calculated possible swing range there will be an estimated 20.81% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $2.23 (2.76%) than the support at $2.04 (5.99%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Earnings coming up
Lyell Immunopharma, Inc. will release earnings BMO on Thursday, May 02, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.200. We will update the financials statements for Lyell Immunopharma, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 7.00% in the first trading day after earnings release.
Is Lyell Immunopharma, Inc. stock A Buy?
The Lyell Immunopharma, Inc. stock holds several negative signals and despite the positive trend, we believe Lyell Immunopharma, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
Current score: -2.104 Sell Candidate Unchanged
Predicted Opening Price for Lyell Immunopharma, Inc. of Monday, April 29, 2024
| Fair opening price April 29, 2024 | Current price |
|---|---|
| $2.16 ( 0.307%) | $2.17 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for LYEL
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 2.26 | 4.30 % | |
| R2 | 2.23 | 2.54 % | ||
| R1 | 2.20 | 1.45 % | ||
| Current price: | 2.17 | |||
| Support | S1 | 2.13 | -2.07 % | |
| S2 | 2.10 | -3.16 % | ||
| S3 | 2.06 | -4.92 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 2.52 | 16.13 % | |
| R2 | 2.41 | 11.06 % | ||
| R1 | 2.23 | 2.76 % | ||
| Current price | 2.17 | |||
| Support | S1 | 2.04 | -5.99% | |
| S2 | 1.99 | -8.29% | ||
| S3 | 1.92 | -11.52% |
FAQ
Click here for our free guide on how to buy Lyell Immunopharma, Inc. Stock.
